The estimated Net Worth of Sukumar Nagendran is at least $339 Tysiąc dollars as of 16 May 2023. Sukumar Nagendran owns over 5,000 units of Solid Biosciences Inc stock worth over $256,353 and over the last 8 years he sold SLDB stock worth over $0. In addition, he makes $82,465 as Independent Director at Solid Biosciences Inc.
Sign up
Sukumar Nagendran SLDB stock SEC Form 4 insiders trading
Sukumar has made over 14 trades of the Solid Biosciences Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of SLDB stock worth $3,400 on 16 May 2023.
The largest trade he's ever made was buying 10,000 units of Solid Biosciences Inc stock on 2 February 2022 worth over $80,100. On average, Sukumar trades about 1,039 units every 64 days since 2016. As of 16 May 2023 he still owns at least 34,226 units of Solid Biosciences Inc stock.
You can see the complete history of Sukumar Nagendran stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sukumar Nagendran biography
Dr. Sukumar Nagendran, M.D. is the Director of the Company. Since February 2020, Dr. Nagendran has served as Chief Medical Officer of an unnamed biopharmaceutical holding company. Prior to that, he was most recently the Chief Medical Officer & Senior Vice President of AveXis Inc., a clinical-stage gene therapy company, or AveXis, from September 2015 to July 2018, prior to the company’s acquisition by Novartis. Prior to AveXis, Dr. Nagendran was Vice President of Medical Affairs of Quest Diagnostics from March 2013 to September 2015. Prior to Quest Diagnostics, Dr. Nagendran held key leadership positions at Pfizer, Novartis, Daiichi Sankyo, and Reata Pharmaceuticals. Prior to moving to the biotech industry, Dr. Nagendran practiced internal medicine, with a focus on diabetes and cardiovascular disease. He is a Mayo Alumni Laureate and founding member of the Robert Wood Johnson Legacy Society. He is also the sponsor for the Fonseca-Nagendran Scholar award at the American Diabetes Association to enhance research in minority populations. Dr. Nagendran received his undergraduate degree in Biochemistry from Rutgers University and his M.D. from Rutgers Medical School and trained in Internal Medicine at Mayo Clinic, Rochester. Dr. Nagendran is qualified to serve on our board of directors because of his extensive leadership experience and his experience working in the healthcare sector.
What is the salary of Sukumar Nagendran?
As the Independent Director of Solid Biosciences Inc, the total compensation of Sukumar Nagendran at Solid Biosciences Inc is $82,465. There are 10 executives at Solid Biosciences Inc getting paid more, with Carl Morris having the highest compensation of $4,052,210.
How old is Sukumar Nagendran?
Sukumar Nagendran is 54, he's been the Independent Director of Solid Biosciences Inc since 2018. There are 4 older and 16 younger executives at Solid Biosciences Inc. The oldest executive at Solid Biosciences Inc is Stephen J. DiPalma M.B.A., 62, who is the Treasurer & Principal Accounting Officer.
What's Sukumar Nagendran's mailing address?
Sukumar's mailing address filed with the SEC is C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN, MA, 02129.
Insiders trading at Solid Biosciences Inc
Over the last 7 years, insiders at Solid Biosciences Inc have traded over $9,620,465 worth of Solid Biosciences Inc stock and bought 13,973,934 units worth $97,227,521 . The most active insiders traders include Advisors Llcperceptive Life..., Capital Management, L.P.Ra ... oraz Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $1,822,871. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth $24,380.
What does Solid Biosciences Inc do?
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
What does Solid Biosciences Inc's logo look like?
Complete history of Sukumar Nagendran stock trades at Solid Biosciences Inc i Taysha Gene Therapies
Solid Biosciences Inc executives and stock owners
Solid Biosciences Inc executives and other stock owners filed with the SEC include:
-
Carl Morris,
Chief Scientific Officer -
Ilan Ganot,
President, Chief Executive Officer, Co-Founder, Director -
Jennifer Ziolkowski,
Chief Financial Officer, Treasurer -
Ilan Ganot,
Co-founder, Pres, CEO & Director -
Dr. Carl Ashley Morris,
Chief Scientific Officer -
Adam Koppel,
Independent Director -
Lynne Sullivan,
Independent Director -
Martin Freed,
Independent Director -
Dr. Andrey Juan Zarur Ph.D.,
Co-Founder -
Adam Stone,
Independent Director -
Sukumar Nagendran,
Independent Director -
Matthew Arnold,
Independent Director -
Rajeev Shah,
Independent Director -
Robert Huffines,
Independent Director -
Ian F. Smith A.C.A., ACA, C.P.A., CPA,
Exec. Chair -
Matthew Bennett Arnold,
Co-Founder & Board Member -
Carlo Tanzi,
IR Contact Officer -
Lynette Herscha,
Chief Legal Officer and Secretary -
Joel Schneider,
Chief Technology Officer and Head of Exploratory Research and Development -
Ian Smith,
Chairman of the Board -
Gilad David Hayeem,
Co-Founder -
Dr. Cathryn M. Clary M.B.A., M.D.,
Acting Chief Medical Officer -
Erin Powers Brennan,
Chief Legal Officer & Sec. -
Caitlin Lowie,
VP of Communications & IR -
Stephen J. DiPalma M.B.A.,
Treasurer & Principal Accounting Officer -
Dr. Joel Solomon Zev Schneider Ph.D.,
Chief Operating Officer -
Michael Inbar CPA, M.B.A.,
Sr. VP of Fin. -
Annie Ganot,
Co-Founder & Director of Patient Advocacy -
Pedro Alvaro Amorrortu,
Chief Operating Officer -
Jorge Armando Quiroz,
Chief Medical Officer -
Capital Management, L.P.Ra ...,
-
Advisors Llcperceptive Life...,
-
Chase & Cojpmc Strategic In...,
-
Advisors Llcedelman Joseph ...,
-
Gilad David Hayeem,
10% owner -
Juan Andrey Zarur,
Director -
Kevin Tan,
CFO & Treasurer -
Capital, Llc Boxer,
10% owner -
Capital Management, L.P.Ra ...,
-
Capital Life Sciences Inves...,
-
Advisors Llcperceptive Life...,
-
Capital Management, L.P.Ra ...,
-
Jessie Hanrahan,
Chief Regulatory Officer -
Erin Powers Brennan,
Chief Legal Officer, Secretary -
Clare Kahn,
-
Advisors Llcperceptive Life...,
-
David T Howton,
Chief Operating Officer -
Jennifer Marlowe,
CSO -
Alexander Cumbo,
President and CEO -
Paul Herzich,
Chief Technology Officer -
Gabriel Brooks,
Chief Medical Officer -
Georgia Keresty,